Journal List > J Korean Med Sci > v.20(6) > 1020118

TOOLS
Yim, Park, Lew, Bai, Han, and Shim: Mycobacterium kansasii Pulmonary Diseases in Korea
Original Article
Journal of Korean Medical Science

Journal of Korean Medical Science 2005; 20(6): 957-960.

Published online: 31 December 2005

DOI: https://doi.org/10.3346/jkms.2005.20.6.957

Mycobacterium kansasii Pulmonary Diseases in Korea

Jae-Joon Yim, Young-Kil Park*, Woo Jin Lew*, Gill-Han Bai*, Sung Koo Han, Young-Soo Shim

Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine and Lung Institute, Seoul National University College of Medicine, Seoul, Korea.

*Korean Institute of Tuberculosis, Seoul, Korea.

Address for correspondence: Young-Soo Shim, M.D. Department of Internal Medicine, Seoul National University College of Medicine, 28 Yongon-dong, Chongno-gu, Seoul 110-744, Korea. Tel: +82.2-2072-3356, Fax: +82.2-741-3356, ysshim@snu.ac.kr

Received 22 March 2005       Accepted 13 June 2005

Copyright © 2005 The Korean Academy of Medical Sciences

(open-access):

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Mycobacterium kansasii is one of the most common cause of pulmonary diseases due to nontuberculous mycobacteria. We investigated the changing in the number of isolation of M. kansasii and the clinical characteristics of M. kansasii pulmonary disease in Korea. Through searching the database of the Korean Institute of Tuberculosis, we identified the cases of isolated M. kansasii from 1992 to 2002. The number of M. kansasii isolation had increased from once in 1992 to 62 in 2002. Fifteen patients with M. kansasii pulmonary disease were identified during the period January 1997 to December 2002. Twelve patients (80%) were male and fourteen (93%) were from highly industrialized areas. The most common symptom was a cough. Seven patients (47%) had a cavitary lesion and right upper lobe was most commonly involved. Patients responded well to isoniazid and rifampicin based regimens both bacteriologically and radiographically. In conclusion, M. kansasii isolation has increased, especially in highly industrialized areas, as well as other nontuberculous mycobacteria in Korea.

Keywords: Mycobacterium kansasii, Mycobacterium Infections, Atypical, Mycobacteria, Atypical, Korea

INTRODUCTION

Mycobacterium kansasii is a slow growing photochromogen, usually isolated from various water sources (1-4). M. kansasii is the second most commonly isolated nontuberculous mycobacteria (NTM) after M. avium-intracellulare in the United States and Japan (5-8). Furthermore, it is the most common NTM in some areas (9, 10).
The incidence or detection of the disease caused by NTM usually increases with decreasing the prevalence of tuberculosis (TB). Although the prevalence of active TB has dramatically decreased from 5.1% in 1965 to 0.5% in 2002 (11) during the past 40 yr in Korea, there has been no recent report on the change of the annual numbers of NTM isolation including M. kansasii. In this study, we evaluated changes in the number of M. kansasii isolation and examined the clinical characteristics of patients with pulmonary disease due to M. kansasii in Korea.

MATERIALS AND METHODS

Isolation of M. kansasii

To determine the annual number of isolation of M. kansasii in clinical samples, we searched the database of the Korean Institute of Tuberculosis, the referral tuberculosis laboratory. The identification of individual NTM has only been possible because the Korean Institute of Tuberculosis started to identify individual species of NTM through 1992 to 2002; thus we searched the database from 1992 to 2002 and collected data on the annual isolations of the each species of NTM including M. kansasii. During the period from 1992 to 2000, mycobacterial species identifications were performed by the traditional biochemical method (12). From January 2001, the species identification of mycobacteria was performed by the PCR-restriction fragment length polymorphism (RFLP) of the polymorphic region of the rpoB gene (13).

M. kansasii pulmonary disease

We identified patients from whom M. kansasii was isolated from January 1997 to December 2002. Among these, patients with a M. kansasii positive culture on 2 or more times were defined to have a M. kansasii pulmonary disease as suggested before (9). A questionnaire was sent to the responsible physicians, which requested details on; demographic patient characteristics, symptoms, signs, laboratory findings, radiographic findings, treatment regimen, and treatment response. Patients with positive M. tuberculosis culture in the same period, incomplete clinical record were excluded for the analysis, and patients with no response to isoniazid and rifampicin-based chemotherapies were also excluded, because we wanted to exclude those NTM simply colonized in their lungs with previous tuberculosis sequelae.

RESULTS

The number of isolation of M. kansasii and other NTM

The total number of mycobacterial colonies referred to Korean Institute of Tuberculosis for identification decreased from 18,970 in 1992 to 5,181 in 2002. In 1992, M. kansasii was identified once (0.2%) from among 448 NTM, and this increased to 62 times (3.6% out of 1,737 colonies) in 2002. During the same period, the number of NTM detections increased from 448 to 1,737. M. avium-intracellulare was found to be the most common through 1992 to 2002, and showed an increasing tendency. M. fortuitum, M. absessus and M. gordonae were also found to increase.

M. kansasii pulmonary diseases

During the period January 1997 to December 2002, M. kansasii was isolated 204 times from 150 patients. Among these, the number of patients positive for M. kansasii by culture 2 or more times was 30. Among these 30 patients, we excluded 7 from analysis because of insufficient clinical data and another 2 due to a positive M. tuberculosis culture in same period. Of the other 21 patients, 6 patients were excluded because their pulmonary lesion in chest radiographs did not improve after at least 6 months of isoniazid and rifampicin-based treatment. Even though M. kansasii was isolated more than twice from the sputum of these 6 patients, we decided that in these patients M. kansasii might be a colonizer rather than a true pathogen.
Among the 150 patients positive for M. kansasii, 76 (51%) lived in Seoul, the largest city in Korea (Fig. 1A). Other highly industrial cities such as, Ulsan (18 patients, 12%), Busan (16 patients, 11%) and Incheon (16 patients, 11%) were also represented. The other patients came also from highly industrialized areas or large cities, only 4 patients lived in rural areas. Fourteen of 15 patients with M. kansasii pulmonary disease were from highly industrialized cities (Fig. 1B).
The median age of the 15 patients with M. kansasii pulmonary disease was 41 yr (range; 26-70) and 12 were men (Table 1). 75% of them were current or ex-smokers and 9 (60%) had a history of previous tuberculosis. Two patients had been diagnosed as having bronchiectasis. Their most common symptom was a cough, of which eight (53%) patients complained; hemoptysis, dyspnea, and fatigue followed. Seven (47%) of 15 patients had cavitary lesions in chest radiographs, 7 patients had nodulostreaky lesions and 1 had consolidation without a cavity. The most frequently involved lung site was the right upper lobe, 52% of all described lesion was found in the right upper lobe.
A combination of isoniazid, rifampicin, pyrazinamide and ethambutol were prescribed initially for 11 patients, and streptomycin was used in combination with these for another 1 patient. Rifampicin, cycloserine, prothionamide and ofloxacin were prescribed initially in one, rifampicin, pyrazinamide, ethambutol and ofloxacin in another, and rifampicin, pyrazinamide, cycloserine, and prothionamide in the remaining patient. The median duration of treatment was 10.5 months, 3 patients experienced hepatotoxicity, and one of these was moved on to other regimen. Three patients experienced myalgia, pruritus or gastrointestinal disturbance, respectively. In 10 of 15 patients with M. kansasii pulmonary diseases, a follow-up mycobacterial culture was performed. Negative conversion of the mycobacterial culture was observed in all 10 patients at 4.0 months (median). In another 3 patients, only follow-up AFB smears were performed, and smear conversion was reported in all 3 at 2.0 months (median) after the initiation of treatment. Neither a subsequent AFB smear nor a culture was performed in the other 2 patients.
Complete resolution of the radiographic lesion was observed in 2 patients, one of these had a cavitary lesion, and the other had a nodulo-streaky lesion. The other 13 patients experienced definite radiographic improvement, but incomplete resolution.

DISCUSSION

M. kansasii is a slow growing photochromogen, which grows over a temperature range from 32 to 42℃. The biochemical identification of M. kansasii has been based on its ability to produce catalase and nitrate reductase, and to hydrolyze Tween 80 (14). M. kansasii has been recovered from water sources. Drinking water distribution systems, tap water and shower heads has been reported to be sources of M. kansasii (1-4). These reports of M. kansasii isolations from water distribution systems, and the fact that this organism can survive in water for up to 12 months (15) support the hypothesis that infection by M. kansasii occurs via an aerosol route (16).
Our results show that the number of isolation of NTM increased from 448 in 1992 to 1,562 in 2002, while the prevalence of active TB over the same period decreased from 1.8% to 0.5% (11). This increase could be due, more probably, to the advances in laboratory methodology and physicians' concern for NTM rather than the decreased prevalence of tuberculosis. In addition, the number of isolation of NTM could be biased because not all mycobacterial colonies isolated had been requested to Korean Institute of Tuberculosis. However, the fact that the total number of mycobacterial colonies requested for identification decreased from 18,970 in 1992 to 5,181 in 2002 suggests the possibility of real increase of NTM prevalence in Korea.
Pulmonary disease caused by M. kansasii is known to be more common in urban areas than in rural areas (10, 17), which concurs with our findings. The Korean patients with M. kansasii in the lung, regardless as to whether it was as a pathogen or as a colonizer, were predominantly living in highly industrialized cities. Half of the patients with M. kansasii lived in Seoul, the largest Korean city of over 10 million people, the next most common location was Ulsan, which is the 7th largest city in Korea, but is heavily industrialized. Other cities represented were Incheon and Busan, which are also highly industrialized. In contrast, few patients were found to be domiciled in the cities of south-west and north-east region of Korea, where agriculture remains the main occupation. This distribution is in accord with a Japanese observation published in 1983 (18) and a study, which reported that 56% of patients with M. kansasii pulmonary disease were employed in heavy industry (19).
The clinical characteristics of M. kansasii pulmonary disease patients in the present study were similar to those of previous reports including Korean cases (10, 19, 20). Thus, the present study confirms an association between M. kansasii pulmonary disease with, a male gender, an urban setting, a history of tuberculosis or of another lung disease as a risk factor, a cough as a common symptom, the presence of a cavitary lesion usually in the right upper lobe, and a response to an isoniazid and rifampicin based regimen
In conclusion, the number of M. kansasii isolation seems to be increasing in Korea. Most of the patients were domiciled in industrialized urban communities, and the clinical characteristics of the patients were similar to those reported previously.

Figures and Tables

Fig. 1
Geographic distribution of patients with a M. kansasii positive culture (A) and probable M. kansasii pulmonary disease (B). Patients not matched with a city were from rural areas.
jkms-20-957-g001
Table 1
The number of NTM isolates from clinical specimens requested for the identification to the Korean Institute for Tuberculosis, 1992-2002
jkms-20-957-i001

*n-a, non-applicable.

Notes

This study was supported by a grant of the Korea Health 21 R&D Project, Ministry of Health & Welfare, Republic of Korea (00-PJ1-PG1-CH03-0001).

Notes

Part of this work was presented under the title of 'NTM in Korea' at the Japanese Tuberculosis Society Meeting 2003 and the summary was published in 'Kekkaku'.

References

1. Bailey RK, Wyles S, Dingley M, Hesse F, Kent GW. The isolation of high catalase Mycobacterium kansasii from tap water. Am Rev Respir Dis. 1970. 101:430–431.
2. McSwiggan DA, Collins CH. The isolation of M. kansasii and M. xenopi from water systems. Tubercle. 1974. 55:291–297.
crossref
3. Engel HW, Berwald LG, Lindeboom BW, Havelaar AH. Mycobacterium kansasii infections in the Netherlands: a brief summary. Rev Infect Dis. 1981. 3:1024.
4. Kaustova J, Olsovsky Z, Kubin M, Zatloukal O, Pelikan M, Hradil V. Endemic occurrence of Mycobacterium kansasii in water-supply systems. J Hyg Epidemiol Microbiol Immunol. 1981. 25:24–30.
5. American Thoracic Society. Diagnosis and treatment of disease caused by nontuberculous mycobacteria. Am J Respir Crit Care Med. 1997. 156:S1–S25.
6. O'Brien RJ, Geiter LJ, Snider DE Jr. The epidemiology of nontuberculous mycobacterial diseases in the United States. Results from a national survey. Am Rev Respir Dis. 1987. 135:1007–1014.
7. Good RC, Snider DE Jr. Isolation of nontuberculous mycobacteria in the United States, 1980. J Infect Dis. 1982. 146:829–833.
crossref
8. Tsukamura M, Kita N, Shimoide H, Arakawa H, Kuze A. Studies on the epidemiology of nontuberculous mycobacteriosis in Japan. Am Rev Respir Dis. 1988. 137:1280–1284.
crossref
9. British Thoracic Society. Management of opportunist mycobacterial infections: Joint Tuberculosis Committee Guidelines 1999. Thorax. 2000. 55:210–218.
10. Ahn CH, Lowell JR, Onstad GD, Shuford EH, Hurst GA. A demographic study of disease due to Mycobacterium kansasii or M intracellulare-avium in Texas. Chest. 1979. 75:120–125.
crossref
11. Hong YP, Kim SJ, Lew WJ, Lee EK, Han YC. The seventh nationwide tuberculosis prevalence survey in Korea, 1995. Int J Tuberc Lung Dis. 1998. 2:27–36.
12. Kent PT, Kubica GP. Public health mycobacteriology: Guide for the Level III Laboratory. 1985. USA: US Department of Health and Human Services, Centers for Disease Control.
13. Lee H, Park HJ, Cho SN, Bai GH, Kim SJ. Species identification of mycobacteria by PCR-restriction fragment length polymorphism of the rpoB gene. J Clin Microbiol. 2000. 38:2966–2971.
14. Jenkins PA, Pattyn SR, Portaels F. Rattledge C, Stanford J, editors. Diagnostic bacteriology. The biology of the mycobacteria. 1982. London: Academic press Ltd.;441–470.
15. Joynson DH. Water: the natural habitat of Mycobacterium kansasii? Tubercle. 1979. 60:77–81.
16. Collins CH, Yates MD. Infection and colonisation by Mycobacterium kansasii and Mycobacterium xenopi: aerosols as a possible source? J Infect. 1984. 8:178–179.
crossref
17. Wolinsky E. Nontuberculous mycobacteria and associated diseases. Am Rev Respir Dis. 1979. 119:107–159.
18. The Mycobacteriosis Research Group of the Japanese National Chest Hospitals. Rapid increase of the incidence of lung disease due to Mycobacterium kansasii in Japan. Chest. 1983. 83:890–892.
19. Kubin M, Svandova E, Medek B, Chobot S, Olsovsky Z. Mycobacterium kansasii infection in an endemic area of Czechoslovakia. Tubercle. 1980. 61:207–212.
crossref
20. Koh WJ, Kwon OJ, Suh JY, Chung MP, Kim H, Lee NY, Kim TS, Lee KS, Park YK, Bai GH. A case report of three patients with nontuberculous mycobacterial pulmonary disease caused by Mycobacterium kansasii. Tuberc Respir Dis. 2003. 54:459–466.
TOOLS
Similar articles